Global Pharmaceutical Drug Delivery Market Report by Commercial Research Company 2022: Market Size, Trends and Forecast to 2026
LONDON, GREATER LONDON, UK, September 6, 2022 /EINPresswire.com/ — According to “Pharmaceutical Drug Delivery Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026” published by The Business Research Company, the pharmaceutical drug delivery market size is expected to reach 1.92 trillion dollars in 2026 at a CAGR of 4.8%. The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market in the future.
Want to know more about the growth of the pharmaceutical drug delivery market? Request a sample now.
The pharmaceutical drug delivery market is the sale of pharmaceutical drug delivery technologies by entities (organizations, sole proprietors, partnerships) used to deliver a pharmaceutical drug to a specific part of the body to treat different diseases. Pharmaceutical drug delivery refers to the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.
Global Pharmaceutical Drug Delivery Market Trends
Adoption of nano drug delivery systems is one of the key trends in the pharmaceutical drug delivery market that is gaining popularity. The use of nanomaterials in pharmaceutical drug delivery can increase the cellular uptake of drugs due to surface charge and time and they can increase the stability and water solubility of drugs. For example, in March 2020, Bioavanta-Boston, a Swiss-based chitosan nanoparticle research organization, released Novochizol, a unique polysaccharide nanotechnology that can be used to encapsulate any effective pharmaceutical additive such as a small molecule or a biological product for localized delivery and regular discharge into any organ or tissue, allowing the treatment of severe COVID-19 infection in the lungs.
Segments of the global pharmaceutical drug delivery market
The Global Pharmaceutical Drug Delivery Market report is segmented:
By route of administration: oral, ocular, pulmonary, nasal, injectable, topical, other
By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Others
By End User: Hospitals, Home Care Facilities, CHWs/Clinics, Others
By Geography: The global Pharmaceutical Drug Delivery Market analysis report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East & Africa. Of these regions, North America accounts for the largest share.
Learn more about the Global Pharmaceutical Drug Delivery Market report here
The Global Pharmaceutical Drug Delivery Market Report 2022 is part of a series of new reports from The Business Research Company that provide global Pharmaceutical Drug Delivery market overviews, size and forecast analysis and forecasts. of the market growth for the global pharmaceutical drug delivery market, the global pharmaceutical drug delivery market share, segments and geographies of the global pharmaceutical drug delivery market, players of the global pharmaceutical drug delivery market, pharmaceutical drugs, revenue, profiles and market shares of major competitors in the global pharmaceutical drug delivery market. The Pharmaceutical Drug Delivery Market report identifies key countries and segments for opportunities and strategies based on market trends and key competitor approaches.
TBRC Global Pharmaceutical Drug Delivery Market 2022 report includes information on the following:
Data segmentation: market size, global, by region and country, historical and forecast, and growth rate for 60 geographies
Main market players: 3M Company, Bayer AG, Becton Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson Inc., Merck & Co Inc, Novartis AG, Pfizer Inc, Sanofi SA, AbbVie Inc. , Amgen Inc., AstraZeneca plc., Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc, Kite Pharma, Nemera France SAS, Nimbus Therapeutics, SHL Medical AG., Teva Pharmaceuticals Industries Ltd. and West Pharmaceutical Services Inc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
Country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Looking for something else? Here is a list of similar reports from The Business Research Company:
Global Implantable Drug Delivery Devices Market Report 2022
Global Injectable Drug Delivery Devices Market Report 2022
Global Implantable Infusion Pump Market Report 2022
About The business research company?
The Business Research Company has published over 1,000 industry reports covering over 2,500 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
The Business Research Society
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Market Research Products, Services and Solutions for Your Business – TBRC